Going Beyond Results of the PEMBRO-RT Trial

JAMA Oncol. 2020 Jan 1;6(1):160-161. doi: 10.1001/jamaoncol.2019.5028.

Authors

Xu Yang¹, Yu Men^{1

2}, Zhouguang Hui^{1

2}

Affiliations

¹ Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
² Department of VIP Medical Services, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

PMID: 31750857
DOI: 10.1001/jamaoncol.2019.5028

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized*
Antineoplastic Combined Chemotherapy Protocols*
Humans

Substances

Antibodies, Monoclonal, Humanized